Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms: HELP
Articles by Reza Kianmanesh
Based on 7 articles published since 2008
||||

Between 2008 and 2019, R. Kianmanesh wrote the following 7 articles about Pancreatic Neoplasms.
 
+ Citations + Abstracts
1 Guideline ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. 2016

Falconi, M / Eriksson, B / Kaltsas, G / Bartsch, D K / Capdevila, J / Caplin, M / Kos-Kudla, B / Kwekkeboom, D / Rindi, G / Klöppel, G / Reed, N / Kianmanesh, R / Jensen, R T / Anonymous1590854. · ·Neuroendocrinology · Pubmed #26742109.

ABSTRACT: -- No abstract --

2 Guideline ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. 2016

Pavel, M / O'Toole, D / Costa, F / Capdevila, J / Gross, D / Kianmanesh, R / Krenning, E / Knigge, U / Salazar, R / Pape, U-F / Öberg, K / Anonymous6880853. ·Charite Virchow Klinikum, Berlin, Germany. ·Neuroendocrinology · Pubmed #26731013.

ABSTRACT: -- No abstract --

3 Guideline ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors. 2009

Akerström, Göran / Falconi, Massimo / Kianmanesh, Reza / Ruszniewski, Philippe / Plöckinger, Ursula / Anonymous1010637 / Anonymous1020637. ·Department of Surgery, Uppsala University Hospital, SE-751 85 Uppsala, Sweden. goran.akerstrom@kirurgi.uu.se ·Neuroendocrinology · Pubmed #19713712.

ABSTRACT: -- No abstract --

4 Review Preoperative imaging and pathologic classification for pancreatic neuroendocrine tumors. 2018

Deguelte, S / de Mestier, L / Hentic, O / Cros, J / Lebtahi, R / Hammel, P / Kianmanesh, R. ·Department of general, digestive and endocrine surgery, Robert-Debré hospital, CHU de Reims, Reims Champagne-Ardenne university, 8, rue du général Koenig, 51100 Reims, France. · Department of gastroenterology, Beaujon hospital, University Paris 7, AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France. · Department of pathology, Beaujon hospital, University Paris 7, AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France. · Department of nuclear medecine, Beaujon hospital, University Paris 7, AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France. · Department of general, digestive and endocrine surgery, Robert-Debré hospital, CHU de Reims, Reims Champagne-Ardenne university, 8, rue du général Koenig, 51100 Reims, France. Electronic address: rkianmanesh@chu-reims.fr. ·J Visc Surg · Pubmed #29397338.

ABSTRACT: The management of patients with pancreatic neuroendocrine tumor (PNET), whether hormonally secretory or not, is multidisciplinary and often multimodal. Surgical treatment plays a central role because complete resection is the only potentially curative treatment. The choice of the therapeutic plan for a PNET requires precise localization of the primary tumor (which may sometimes be multiple in case of genetic predisposition), confirmation of the diagnosis of PNET, a search for metastases (mainly hepatic), and identification of the main histoprognostic factors. This update focuses on the WHO 2017 histological classification and recent innovations in the preoperative assessment of PNET using conventional and isotopic imaging. The aim is to not only allow the mapping of primary and metastatic lesions but also to predict tumor aggressiveness.

5 Review Pancreas cancer-associated polymyositis of the legs regressing after cephalic duodenopancreatectomy: case report and review of the literature. 2012

Amroun, Koceila Lamine / De Mestier, Louis / Deguelte-Lardiere, Sophie / Diebold, Marie-Danièle / Bouché, Olivier / Kianmanesh, Reza. ·Service of General, Digestive and Endocrine Surgery, Robert-Debré Hospital. Reims, France. lamroun@chu-reims.fr ·JOP · Pubmed #23183398.

ABSTRACT: CONTEXT: Inflammatory myopathy, such as polymyositis, has been widely reported as paraneoplastic syndrome associated with various malignancies. However, its association with pancreas adenocarcinoma is very uncommon. CASE REPORT: A case of a patient with paraneoplastic polymyositis of both legs associated with pancreatic adenocarcinoma is reported here. The diagnosis of polymyositis was highlighted by MRI and confirmed by histopathological examination. The surgical resection of the primary tumor led to the complete resolution of polymyositis with no further recurrence despite later metastases. CONCLUSION: The association between pancreatic cancer and paraneoplastic polymyositis is very uncommon and has to be recognized by clinicians.

6 Article ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. 2012

Jensen, Robert T / Cadiot, Guillaume / Brandi, Maria L / de Herder, Wouter W / Kaltsas, Gregory / Komminoth, Paul / Scoazec, Jean-Yves / Salazar, Ramon / Sauvanet, Alain / Kianmanesh, Reza / Anonymous60716. ·Digestive Diseases Branch, NIH, Bethesda, MD 20892, USA. robertj@bdg10.niddk.nih.gov ·Neuroendocrinology · Pubmed #22261919.

ABSTRACT: -- No abstract --

7 Article Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience. 2009

Scigliano, S / Lebtahi, R / Maire, F / Stievenart, J L / Kianmanesh, R / Sauvanet, A / Vullierme, M P / Couvelard, A / Belghiti, J / Ruszniewski, P / Le Guludec, D. ·Department of Nuclear Medicine, Beaujon University Hospital, 100 Boulevard du Général Leclerc, Clichy 92110, France. sciglsonia@yahoo.fr ·Endocr Relat Cancer · Pubmed #19470616.

ABSTRACT: Liver metastases are common in gastroenteropancreatic neuroendocrine tumors and significantly impair survival. Hepatic resection is the only potential curative treatment. The records of 41 consecutive patients undergoing exhaustive resection of liver-only endocrine metastases and followed between 1992 and 2006 were reviewed. Patient's outcome and diagnostic accuracy of somatostatin receptor scintigraphy (SRS) and morphological imaging (MI) for detection of recurrences during post-operative follow-up were assessed. All identified primary had been resected. MI studies including abdominal computed tomography (CT) and/or liver magnetic resonance imaging and thoracic CT if indicated were performed every 6 months; SRS timing was decided by referring clinician. Tumor recurrences were confirmed by pathology or subsequent imaging studies. The results of 136 MI and SRS examinations performed within a 30-day interval from each other were retrospectively compared. Median post-operative follow-up was 51 months (7-165). Recurrences developed in 32 patients (78%), mainly in the liver (n=24) after a median of 19 months (2-79). Five-year overall and disease-free survival rates were 79 and 3% respectively. For recurrence detection, sensitivity, specificity, and accuracy were 89, 94, and 91% for SRS, 68, 91, and 74% for MI respectively. In 11 out of 32 patients (34%), abdominal or extra-abdominal metastases were detected 15.5 months earlier by SRS than MI. In conclusion, despite exhaustive liver surgery for endocrine metastases, hepatic or extra-hepatic recurrences are frequent and develop early. SRS is highly accurate for the detection of recurrences during post-operative follow-up and permitted early diagnosis in one third of patients; therapeutic implications of this early diagnosis remain to be determined.